Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Joan Bel"'
Autor:
Laia Gomez-Muñoz, David Perna-Barrull, Josep M. Caroz-Armayones, Marta Murillo, Silvia Rodriguez-Fernandez, Aina Valls, Federico Vazquez, Jacobo Perez, Raquel Corripio, Luis Castaño, Joan Bel, Marta Vives-Pi
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/d946255df1a24637a2d10b2a7920b4a5
Autor:
Laia Gomez-Muñoz, David Perna-Barrull, Adrian Villalba, Silvia Rodriguez-Fernandez, Rosa-Maria Ampudia, Aina Teniente-Serra, Federico Vazquez, Marta Murillo, Jacobo Perez, Raquel Corripio, Joan Bel, Marta Vives-Pi
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/fe4e09f9ddbe47b094d955e42bde0dbb
Autor:
Marta Murillo-Vallés, Santiago Martinez, Cristina Aguilar-Riera, Miguel Angel Garcia-Martin, Joan Bel-Comós, Maria Luisa Granada Ybern
Publikováno v:
BMC Pediatrics, Vol 20, Iss 1, Pp 1-6 (2020)
Abstract Background Subclinical hypothyroidism (SH) is defined as serum levels of thyroid-stimulating hormone (TSH) above the upper limit with normal concentrations of free T4 (fT4). Its management remains challenging. The aim of the study was to eva
Externí odkaz:
https://doaj.org/article/0aad070781444a43895ba64fbf5d119a
Autor:
Siri D. Taxerås, María Galán, Laura Campderros, Irene Piquer‐Garcia, Silvia Pellitero, Eva Martínez, Rocío Puig, Icíar Lucena, Jordi Tarascó, Pau Moreno, José Balibrea, Joan Bel, Marta Murillo, María Martínez, Marta Ramon‐Krauel, Manel Puig‐Domingo, Francesc Villarroya, Carles Lerin, David Sánchez‐Infantes
Publikováno v:
Obesity Science & Practice, Vol 6, Iss 1, Pp 99-106 (2020)
Summary Objectives S100A4 has been recently identified as an adipokine associated with insulin resistance (IR) in adult subjects with obesity. However, no data about its levels in children with obesity and only a few approaches regarding its potentia
Externí odkaz:
https://doaj.org/article/c7de69669df94d46a3348ddb1a54917d
Autor:
Laia Gomez-Muñoz, David Perna-Barrull, Josep M. Caroz-Armayones, Marta Murillo, Silvia Rodriguez-Fernandez, Aina Valls, Federico Vazquez, Jacobo Perez, Raquel Corripio, Luis Castaño, Joan Bel, Marta Vives-Pi
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The partial remission (PR) phase, a period experienced by most patients with type 1 diabetes (T1D) soon after diagnosis, is characterized by low insulin requirements and improved glycemic control. Given the great potential of this phase as a therapeu
Externí odkaz:
https://doaj.org/article/583b883237ef4d5a90367b7a3cab653f
Autor:
David Perna-Barrull, Marta Murillo, Nati Real, Laia Gomez-Muñoz, Silvia Rodriguez-Fernandez, Joan Bel, Manel Puig-Domingo, Marta Vives-Pi
Publikováno v:
Journal of Diabetes Research, Vol 2022 (2022)
Background. Betamethasone, a glucocorticoid used to induce lung maturation when there is a risk of preterm delivery, can affect the immune system maturation and type 1 diabetes (T1D) incidence in the progeny. It has been described that prenatal betam
Externí odkaz:
https://doaj.org/article/afc39d22ac9949ae926c1b9f1f7d011f
Autor:
Laia Gomez-Muñoz, David Perna-Barrull, Adrian Villalba, Silvia Rodriguez-Fernandez, Rosa-Maria Ampudia, Aina Teniente-Serra, Federico Vazquez, Marta Murillo, Jacobo Perez, Raquel Corripio, Joan Bel, Marta Vives-Pi
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
Type 1 diabetes (T1D) is a chronic metabolic disease characterized by the autoimmune destruction of β-cells in the pancreatic islets. T1D is preceded by islet-specific inflammation led by several immune cells. Among them, natural killer (NK) cells a
Externí odkaz:
https://doaj.org/article/bb88041d94bd41f4939c9e73c22b11b0
Autor:
Silvia Rodriguez-Fernandez, Marta Murillo, Adrian Villalba, David Perna-Barrull, Mary Cano-Sarabia, Laia Gomez-Muñoz, Eva Aguilera, Daniel Maspoch, Federico Vazquez, Joan Bel, Marta Vives-Pi
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Type 1 diabetes (T1D) is prompted by defective immunological tolerance, an event in which dendritic cells (DCs) are crucial as immune response orchestrators. In fact, they contribute to maintaining tolerance to self-antigens, but they can also prompt
Externí odkaz:
https://doaj.org/article/19af0f58ed9f4b98a4e3dcd3fcc6abe0
Autor:
Marta Murillo, Mireia Fonolleda, Laura Bosch, Silvia Rodríguez-Fernández, Federico Vázquez, Joan Bel, Marta Vives-Pi
Publikováno v:
Journal of Clinical and Translational Endocrinology Case Reports, Vol 6, Iss , Pp 11-13 (2017)
Spontaneous, partial and transient remission of type 1 diabetes (T1D) is a period that requires minor doses of exogenous insulin and lasts a few months. We present an 18-year-old girl, diagnosed at 12 years with T1D, with spontaneous and partial remi
Externí odkaz:
https://doaj.org/article/078f2e8afdbe4c3191d389500ea56189
Autor:
Aina Teniente-Serra, Joan Bel, Silvia Rodriguez-Fernandez, Rosa-Maria Ampudia, Laia Gomez-Muñoz, Federico Vázquez, Raquel Corripio, Marta Murillo, Jacobo Perez, Adrian Villalba, David Perna-Barrull, Marta Vives-Pi
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
Frontiers in Immunology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Frontiers in Immunology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Type 1 diabetes (T1D) is a chronic metabolic disease characterized by the autoimmune destruction of β-cells in the pancreatic islets. T1D is preceded by islet-specific inflammation led by several immune cells. Among them, natural killer (NK) cells a